| 1 |
Park C, Hsu C, Neelakanta G, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation[J]. Transplantation, 2009, 87(7): 1031-1036.
|
| 2 |
Wallia A, Parikh ND, Molitch ME, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection[J]. Transplantation, 2010, 89(2): 222-226.
|
| 3 |
Chung HS, Kim ES, Rho MC, et al. Contribution of donor factors to post-reperfusion severe hyperglycemia in patients undergoing living donor liver transplantation[J]. Ann Transplant, 2015, 20: 303-311.
|
| 4 |
Jin HY, Lee KA, Kim YJ, et al. The degree of hyperglycemia excursion in patients of kidney transplantation (KT) or liver transplantation (LT) assessed by continuous glucose monitoring (CGM): pilot study[J]. J Diabetes Res, 2019, 2019: 1757182.
|
| 5 |
Oliveira RA, Mancero JMP, Faria DF, et al. A retrospective cohort study of risk factors for surgical site infection following liver transplantation[J]. Prog Transplant, 2019, 29(2): 144-149.
|
| 6 |
Hamed AE, Elsahar M, Elwan NM, et al. Managing diabetes and liver disease association[J]. Arab J Gastroenterol, 2018, 19(4)：166-179.
|
| 7 |
Chung HS, Lee S, Kwon SJ, et al. Perioperative predictors for refractory hyperglycemia during the neohepatic phase of liver transplantation[J]. Transplant Proc, 2014, 46(10): 3474-3480.
|
| 8 |
Park CS. Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation[J]. World J Gastroenterol, 2015, 21(22): 6835-6841.
|
| 9 |
Shangraw RE, Hexem JG. Glucose and potassium metabolic responses to insulin during liver transplantation[J]. Liver Transpl Surg, 1996, 2(6)：443-454.
|
| 10 |
Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis[J]. Exp Clin Endocrinol Diabetes, 1995, 103(2): 63-74.
|
| 11 |
Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism[J]. Lancet, 2010, 375(9733): 2267-2277.
|
| 12 |
Hung CH, Lee CM, Lu SN. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications[J]. Expert Rev Anti Infect Ther, 2011, 9(5): 525-533.
|
| 13 |
Kajbaf F, Mojtahedzadeh M, Abdollahi M. Mechanisms underlying stress-induced hyperglycemia in critically ill patients[J]. Therapy, 2007, 4(1): 97-106.
|
| 14 |
Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner[J]. J Anesth, 2005, 19(4): 277-281.
|
| 15 |
Diltoer M, Camu F. Glucose homeostasis and insulin secretion during isoflurane anesthesia in humans[J]. Anesthesiology, 1988, 68(6): 880-886.
|
| 16 |
Iwasaka H, Itoh K, Miyakawa H, et al. Glucose intolerance during prolonged sevoflurane anaesthesia[J]. Can J Anaesth, 1996, 43(10): 1059-1061.
|
| 17 |
Fang X, Xia T, Xu F, et al. Isoflurane aggravates peripheral and central insulin resistance in high-fat diet/streptozocin-induced type 2 diabetic mice[J]. Brain Res, 2020, 1727：146511.
|
| 18 |
Kim SP, Broussard JL, Kolka CM. Isoflurane and sevoflurane induce severe hepatic insulin resistance in a canine model[J]. PLoS One, 2016, 11(11): e0163275.
|
| 19 |
Yu Q, Li J, Dai CL, et al. Anesthesia with sevoflurane or isoflurane induces severe hypoglycemia in neonatal mice[J]. PLoS One, 2020, 15(4): e0231090.
|
| 20 |
罗朝志，王健，王泉云，等. 原位肝移植术中病人血生化的变化[J]. 四川医学，2000, 21(10): 856-858.
|
| 21 |
Maeda H, Okabayashi T, Nishimori I, et al. Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration[J]. Am J Surg, 2010, 199(1): 8-13.
|
| 22 |
Hu Y, Yang C, Shen G, et al. Hyperglycemia-triggered sphingosine-1-phosphate and sphingosine-1-phosphate receptor 3 signaling worsens liver ischemia/reperfusion injury by regulating M1/M2 polarization[J]. Liver Transpl, 2019, 25(7): 1074-1090.
|
| 23 |
Liu C, Wang X, Chen Z, et al. Hepatic ischemia-reperfusion induces insulin resistance via down-regulation during the early steps in insulin signaling in rats[J]. Transplant Proc, 2008, 40(10): 3330-3334.
|
| 24 |
Vanhorebeek I, Van den Berghe G. The neuroendocrine response to critical illness is a dynamic process[J]. Crit Care Clin, 2006, 22(1): 1-15.
|
| 25 |
Takano A, Haruta T, Iwata M, et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes[J]. Diabetes, 2001, 50(8): 1891-1900.
|
| 26 |
Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response！[J]. Crit Care Med, 2013, 41(6): e93-e94.
|
| 27 |
Dhatariya K, Corsino L, Umpierrez GE. Management of diabetes and hyperglycemia in hospitalized patients[M]. South Dartmouth (MA): Endotext [Internet], 2020.
|
| 28 |
Sies H. Oxidative stress: a concept in redox biology and medicine[J]. Redox Biol, 2015, 4: 180-183.
|
| 29 |
Luc K, Schramm-Luc A, Guzik TJ, et al. Oxidative stress and inflammatory markers in prediabetes and diabetes[J]. J Physiol Pharmacol, 2019, 70(6): 809-824.
|
| 30 |
Mifsud S, Schembri EL, Gruppetta M. Stress-induced hyperglycaemia[J]. Br J Hosp Med (Lond), 2018, 79(11): 634-639.
|
| 31 |
Esguerra JLS, Ofori JK, Nagao M, et al. Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA[J]. Mol Metab, 2020, 32: 160-167.
|
| 32 |
Özdemir H, Memişoǧlu A, Alp-Unkar Z, et al. Persistent hyperglycemia in a neonate: Is it a complication of therapeutic hypothermia？[J]. Turk J Pediatr, 2017, 59(2): 193-196.
|
| 33 |
李晓博. 综合性保温措施对人工髋关节置换术患者术中血糖水平的影响[J/CD]. 世界最新医学信息文摘(电子版), 2015, 15(14): 3-4.
|
| 34 |
Szilágyi ÁL, Mátrai P, Hegyi P, et al. Compared efficacy of preservation solutions on the outcome of liver transplantation: meta-analysis[J]. World J Gastroenterol, 2018, 24(16): 1812-1824.
|
| 35 |
Atchison SR, Rettke SR, Fromme GA, et al. Plasma glucose concentrations during liver transplantation [J]. Mayo Clin Proc, 1989, 64(2): 241-245.
|
| 36 |
Yoo S, Lee HJ, Lee H, et al. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation[J]. Anesth Analg, 2017, 124(1): 35-41.
|
| 37 |
Baird TA, Parsons MW, Phan T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome[J]. Stroke, 2003, 34(9): 2208-2214.
|
| 38 |
王芳，钱玥，夏天娇，等. 围手术期血糖水平与术后认知功能障碍的研究进展[J]. 国际麻醉学与复苏杂志，2020, 41(7): 686-691.
|
| 39 |
Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview[J]. Lancet, 2000, 355(9206): 773-778.
|
| 40 |
Simha V, Shah P. Perioperative glucose control in patients with diabetes undergoing elective surgery[J]. JAMA, 2019, 321(4): 399-400.
|
| 41 |
Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients[J]. Mayo Clin Proc, 2005, 80(7): 862-866.
|
| 42 |
Perito ER, Lustig RH, Rosenthal P. Prediabetes in pediatric recipients of liver transplant: mechanism and risk factors[J]. J Pediatr, 2017, 182: 223-231.e3.
|
| 43 |
Peláez-Jaramillo MJ, Cárdenas-Mojica AA, Gaete PV, et al. Post-liver transplantation diabetes mellitus: a review of relevance and approach to treatment[J]. Diabetes Ther, 2018, 9(2): 521-543.
|
| 44 |
Ammori JB, Sigakis M, Englesbe MJ, et al. Effect of intraoperative hyperglycemia during liver transplantation[J]. J Surg Res, 2007, 140(2): 227-233.
|
| 45 |
Blasi A, Beltran J, Martin N, et al. Transient hyperglycemia during liver transplantation does not affect the early graft function[J]. Ann Hepatol, 2015, 14(5)：675-687.
|
| 46 |
Park C, Huh M, Steadman RH, et al. Extended criteria donor and severe intraoperative glucose variability: association with reoperation for hemorrhage in liver transplantation[J]. Transplant Proc, 2010, 42(5): 1738-1743.
|
| 47 |
Kang R, Han S, Lee KW, et al. Portland intensive insulin therapy during living donor liver transplantation: association with postreperfusion hyperglycemia and clinical outcomes[J]. Sci Rep, 2018, 8(1): 16306.
|
| 48 |
Gedik E, I·lksen Toprak H, Koca E, et al. Blood glucose regulation during living-donor liver transplant surgery[J]. Exp Clin Transplant, 2015, 13(Suppl 1): S294-S300.
|
| 49 |
Okada T, Kawahito S, Mita N, et al. Usefulness of continuous blood glucose monitoring and control for patients undergoing liver transplantation[J]. J Med Invest, 2013, 60(3-4): 205-212.
|
| 50 |
陈莉明，陈伟，陈燕燕，等. 成人围手术期血糖监测专家共识[J]. 中国糖尿病杂志，2021，29(2)：81-85.
|
| 51 |
Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials[J]. Eur J Intern Med, 2012, 23(6): 564-574.
|
| 52 |
Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis[J]. Chest, 2010, 137(3): 544-551.
|
| 53 |
Yatabe T, Inoue S, Sakaguchi M, et al. The optimal target for acute glycemic control in critically ill patients: a network meta-analysis[J]. Intensive Care Med, 2016, 43(1): 16-28.
|
| 54 |
Kumar SS, Pelletier SJ, Shanks A, et al. Intraoperative glycemic control in patients undergoing orthotopic liver transplant: a single center prospective randomized study[J]. BMC Anesthesiol, 2020, 20(1): 3.
|
| 55 |
Srinivasan V, Agus MS. Tight glucose control in critically ill children - a systematic review and meta-analysis[J]. Pediatr Diabetes, 2014, 15(2): 75-83.
|
| 56 |
Toltzis P. Tight glycemic control in critically ill children[J]. J Pediatr, 2020, 218：1-4.
|
| 57 |
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients[J]. N Engl J Med, 2009, 360(13): 1283-1297.
|